Loading...
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
One third of the world is infected with Mycobacterium tuberculosis (Mtb) with eight million new cases of active tuberculosis (TB) each year. Development of a new vaccine to augment or replace the only approved TB vaccine, BCG, is needed to control this disease. Mtb infection is primarily controlled...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3871206/ https://ncbi.nlm.nih.gov/pubmed/23933525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2013.07.030 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|